Biotime Inc., of Alameda, Calif., received the second installment payment of $10.8 million pursuant to the previously disclosed sale of shares of Agex Therapeutics Inc., also of Alameda,, Calif., to Juvenescence Ltd., an investment firm in the British Virgin Islands.